Taking Added Advantage Of Reality: Johnson & Johnson, Pfizer, Qualcomm, Visa, Berkshire Hathaway
- Friday, February 22, 2013, 11:19
- Market
- Add a comment
Barry Ritholtz, CEO and Director of Equity Research, Fusion IQ
http://www.forbes.com/sites/wallaceforbes/2013/02/22/taking-added-advantage-of-reality-johnson-johnson-pfizer-qualcomm-visa-berkshire-hathaway/
About the Author
admin123 has written 23402 stories on this site.
